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Effects of continuous positive airway pressure 
(CPAP) sleep apnea treatment on mild cognitive 
impairment (MCI), a precursor state to 
Alzheimer’s disease 
Olivia Taylor, Cynthia Cheng, MD, PhD* 
Introduction
• Current estimates report the prevalence of obstructive sleep apnea (OSA) in the 
United States to be 7-9%of the population, thus affecting about 26 million people1, 
many who are unaware of their condition
Introduction
• My role in this multi-site project was to screen potential 
patients from Jefferson’s sleep clinic for eligibility for study 
enrollment.
• Some positive preliminary data - CPAP therapy does seem 
to have a beneficial effect as hypothesized on 
neuropsychiatric testing, indicating a possible benefit in 
slowing the progression of MCI
• COVID delays led to my being less needed on this project in 
year 2
• Currently I am playing a key role in a related project examining 
the effect of CPAP compliance on cardiovascular risk and 
cardiovascular risk factors in OSA patients.
• This is what I will be discussing for the rest of today
• OSA can have many, varied detrimental effects on the cardiovascular system 





– What is the observed difference in heart rate before and 
after initiating CPAP therapy in moderate-severe OSA (AHI 
>= 15) patients who are compliant and noncompliant with 
CPAP?
• Hypothesis
– Compliance with CPAP therapy (>= 4 hrs of usage/night for 
70% of nights/month) leads to a decrease in average 
annual heart rate measurements compared to 
noncompliant/non CPAP users.
Approach & Results
• Retrospective/prospective cohort study
• Patients with moderate-severe OSA (identified from 
Jefferson Sleep Medicine center) - 2000+ patients 
• Intervention was CPAP therapy, separated into 
compliant, noncompliant, and non-CPAP control 
patients
• EPIC chart reviews, smart card (from CPAP machine) 
compliance data analyzed  
• Many markers of cardiovascular health are being 




– A 10 patient preliminary data analysis was completed using SAS 9.4 
Findings
HR change in the CPAP 
compliant group was 
1.3 + 7.5 (decrease 
of 1.3, n=5)
Compared to the 
control group (no 
CPAP), 0.5 + 2.8 
(decrease of 0.5, 
n=3)
The p value was not 
significant, likely due to 
the small sample size as 
well as the small 
difference in heart rate 
between the groups.  
Conclusions
• Our findings are still interesting even though the sample 
size is so small
• The work that has been done for the past several months 
was mostly setting up the database and protocol so that 
future students can collect the sample size needed to 
follow out the trends
• Excited that the preliminary heart rate finding is in the 
expected direction, demonstrating more of a heart rate 
drop for the CPAP group compared to control
•  This is positive because lower heart rate is better for CV 
risk
Future Directions
• Now that the protocol, variables, and database are 
all set, future students can help reach the goal of 
2000+ patients included in the study
• More patients and a longer study period (more data 
points per patient) will strengthen the study power
• The preliminary data analysis showed trends in the 
direction towards improving heart rate, which is a 
predictor of CV risk, which is encouraging (although 
this was not significant)  
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